Skip to main content

Table 1 Baseline T2* values and period of exposure to each chelation regime between MR scans.

From: The efficacy of iron chelator regimes in reducing cardiac and hepatic iron in patients with thalassaemia major: a clinical observational study

Parameter, mean (SD)

Treatment

 

DFO

DFP

DFP & DFO

DFX

ANOVA F-test p-value

Heart T2*

21.4 (12.6)

15.7 (9.6)

16.6 (10.8)

27 (9.5)

<0.0001

Liver T2*

6.2 (5.5)

10.6 (9.3)

5 (5.3)

5.3 (6.8)

0.0004

Exposure period (months)

24 (11.5)

25.6 (13.2)

26.8 (12.6)

17.3 (7)

<0.0001

Intervals between MR scans (months)

19.1 (9.6)

17.2 (11.3)

19 (9.5)

14 (4.5)

0.0001